
|Articles|January 1, 2002
Griseofulvin should remain standard in tinea capitis
Munich - Newer oral antifungals have efficacy similar to griseofulvin in tinea capitis, possibly with a shorter duration of therapy. But for now, the old and familiar standby should remain the treatment of choice, according to Peter Mayser, M.D., senior physician, Justus Liebig University, Giessen, Germany.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
Expert Panel Unanimously Backs DecisionDx-Melanoma for Guiding Personalized Cancer Care
4
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
5

















